Wangting Xu

482 total citations
10 papers, 295 citations indexed

About

Wangting Xu is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wangting Xu has authored 10 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wangting Xu's work include Ferroptosis and cancer prognosis (3 papers), Phagocytosis and Immune Regulation (2 papers) and Epigenetics and DNA Methylation (2 papers). Wangting Xu is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Phagocytosis and Immune Regulation (2 papers) and Epigenetics and DNA Methylation (2 papers). Wangting Xu collaborates with scholars based in China and United States. Wangting Xu's co-authors include Xue Zhang, Hongqiang Cheng, Yuehai Ke, Yiqing Li, Yaru Liu, Pengwei Zhao, Di Wang, Yuxian Guo, Bufu Tang and Qiaoyou Weng and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Wangting Xu

10 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangting Xu China 6 187 104 72 67 44 10 295
Seunghyeong Lee South Korea 9 202 1.1× 80 0.8× 83 1.2× 156 2.3× 69 1.6× 10 356
Kyung‐Min Yang South Korea 12 284 1.5× 47 0.5× 55 0.8× 68 1.0× 66 1.5× 22 413
Weiwei Cui China 8 227 1.2× 176 1.7× 40 0.6× 156 2.3× 30 0.7× 13 351
Hao-Ran Jin China 4 142 0.8× 39 0.4× 47 0.7× 130 1.9× 45 1.0× 7 274
Yuanwei Zang China 12 197 1.1× 71 0.7× 48 0.7× 115 1.7× 70 1.6× 21 375
Jong Woo Kim South Korea 9 168 0.9× 91 0.9× 44 0.6× 78 1.2× 15 0.3× 17 323
Krizia Rohena-Rivera United States 6 135 0.7× 87 0.8× 44 0.6× 97 1.4× 108 2.5× 8 277
Feng Dong China 10 281 1.5× 118 1.1× 40 0.6× 204 3.0× 39 0.9× 18 439
Yiran Yao China 8 215 1.1× 44 0.4× 51 0.7× 113 1.7× 82 1.9× 12 363
Shuye Lin China 11 162 0.9× 46 0.4× 47 0.7× 71 1.1× 51 1.2× 18 270

Countries citing papers authored by Wangting Xu

Since Specialization
Citations

This map shows the geographic impact of Wangting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangting Xu more than expected).

Fields of papers citing papers by Wangting Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangting Xu. The network helps show where Wangting Xu may publish in the future.

Co-authorship network of co-authors of Wangting Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wangting Xu. A scholar is included among the top collaborators of Wangting Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangting Xu. Wangting Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Guo, Dandan, Songhua Cai, Wangting Xu, et al.. (2025). Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies. MedComm. 6(3). e70116–e70116. 14 indexed citations
2.
Tang, Bufu, Wangting Xu, Shiji Fang, et al.. (2025). MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. Military Medical Research. 12(1). 5–5. 3 indexed citations
3.
Xu, Wangting, Qiao Xu, Peng Luo, et al.. (2025). Gut–Brain–Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors. Research. 8. 885–885. 1 indexed citations
4.
Ying, Kejing, Dandan Lv, Yeping Li, et al.. (2024). NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis. Advanced Science. 11(13). e2308166–e2308166. 1 indexed citations
5.
Cai, Songhua, Yang Zhou, Dandan Guo, et al.. (2024). Targeting SLC7A11 /xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti‐tumor immune response. SHILAP Revista de lepidopterología. 3(6). e248–e248. 11 indexed citations
6.
Li, Yiqing, Hui Zhou, Pan Liu, et al.. (2023). SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis. Journal of Clinical Investigation. 133(4). 36 indexed citations
7.
Tang, Bufu, Yajie Wang, Wangting Xu, et al.. (2022). Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer. Cancer Letters. 554. 216021–216021. 40 indexed citations
8.
Tang, Bufu, Wangting Xu, Yajie Wang, et al.. (2021). Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death. Clinical Immunology. 232. 108872–108872. 50 indexed citations
9.
Guo, Yuxian, Yaru Liu, Wangting Xu, et al.. (2021). Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nature Communications. 12(1). 7094–7094. 134 indexed citations
10.
Huan, Caijuan, Wangting Xu, Yaru Liu, et al.. (2021). Gremlin2 Activates Fibroblasts to Promote Pulmonary Fibrosis Through the Bone Morphogenic Protein Pathway. Frontiers in Molecular Biosciences. 8. 683267–683267. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seunghyeong Lee Breakdown of academic impact, for papers by Kyung‐Min Yang Breakdown of academic impact, for papers by Weiwei Cui Breakdown of academic impact, for papers by Hao-Ran Jin Breakdown of academic impact, for papers by Yuanwei Zang Breakdown of academic impact, for papers by Jong Woo Kim Breakdown of academic impact, for papers by Krizia Rohena-Rivera Breakdown of academic impact, for papers by Feng Dong Breakdown of academic impact, for papers by Yiran Yao Breakdown of academic impact, for papers by Shuye Lin
Rankless by CCL
2026